Indogulf Cropsciences IPO

Indogulf Cropsciences IPO is a bookbuilt issue of ₹200.00 crore. It combines a fresh issue of 1.44 crore shares aggregating to ₹160.00 crores and an offer for sale of 0.36 crore shares aggregating to ₹40.00 crores.

The IPO opens for subscription on June 26, 2025, and closes on June 30, 2025. The allotment is expected to be finalized on Tuesday, July 01, 2025. The price band for the IPO is set at ₹105 to ₹111 per share, and the minimum lot size for an application is 135 shares. 

Company Summary

Incorporated in 1993, Indogulf Cropsciences Limited is engaged in manufacturing crop protection products, plant nutrients, and biologicals in India.

The company manufactured Spiromesifen technical with 96.5% purity in 2019 and is one of the first indigenous manufacturers of Pyrazosulfuron Ethyl technical with 97% purity in India.

The company operates four manufacturing facilities in Samba (Jammu & Kashmir) and Nathupur (Haryana), covering approximately twenty acres, including two sites in Nathupur and one in Barwasni, Haryana.

The company has a sales network across 22 states and 3 Union Territories in India, with 169 business partners, 5,772 distributors, and 129 partners in 34 countries worldwide.

The company’s flexible, multi-purpose facilities allow diverse product manufacturing, adapting to customer needs. Its competitive advantage is strengthened by high regulatory barriers in the agrochemical industry, including costs and complex approvals.

As of August 31, 2024, the company had 640 permanent employees.

Product portfolio

  • Plant Nutrients: The company manufactures specialty fertilizers, bio-simulants, and performance products, including straight fertilizers and soil health products, to enhance soil fertility, stimulate root growth, and improve crop yields.
  • Crop Protection Products: The company manufactures crop protection products, including insecticides, fungicides, herbicides, and bio-stimulants, designed to safeguard crops from pests, diseases, and weeds, ensuring healthy growth and productivity.
  • Biologicals: The company offers biological products, including bio-stimulants and bio-fertilizers, to improve crop growth, nutrient uptake, stress tolerance, and overall sustainability, with products like Biogold, Indo Breeza, and Indo Mycoriza.

Company strength

  • Diversified product portfolio and specialized products across all three verticals.
  • Established distribution network in India and abroad.
  • Backward-integrated manufacturing infrastructure.
  • Strong R&D and product development capabilities.
  • Experienced Promoters and a strong management team.

Company Financials

Period Ended

31 Dec 2024

31 Mar 2024

31 Mar 2023

31 Mar 2022

Assets

597.81

542.25

517.51

413.59

Revenue

466.31

555.79

552.19

490.23

Profit After Tax

21.68

28.23

22.42

26.36

EBITDA

44.78

55.74

49.04

47.24

Net Worth

265.43

231.65

203.25

180.51

Reserves and Surplus

216.64

208.01

179.60

156.87

Total Borrowing

206.30

154.56

189.22

101.38

     Amount in ₹ Crore

Objectives of IPO

Objects of the Issue

Expected amount (₹ in Crore)

Funding working capital requirements of our company

65.00

Repayment/ prepayment, in full or in part, of certain outstanding borrowings availed by our Company

34.12

Capital expenditure of our Company for setting up an in-house dry flowable (DF) plant at Barwasni, District Sonipat, Haryana

14.00

General Corporate Purposes

    –

Promoters of the company

Om Prakash Aggarwal, Sanjay Aggarwal, Anshu Aggarwal, and Arnav Aggarwal are the promoters of the company.

IPO Details

IPO Date

June 26, 2025 to June 30, 2025

Listing Date

July 03, 2025

Face Value

₹10 per share

Price Band

₹105 to ₹111 per share

Lot size

135 shares

Total Issue size

1,80,18,017 shares (aggregating up to ₹200.00 Cr)

Fresh issue

1,44,14,414 shares (aggregating up to ₹160.00 Cr)

Offer for Sale

36,03,603 shares of ₹ 10 (aggregating up to ₹40.00 Cr)

Issue type

Bookbuilding IPO

Listing at

NSE, BSE

Share Holding Pre Issue

4,87,87,456 shares

Share Holding Post Issue

6,32,01,870 shares

Lot Allocation Details

Application

Lots

Shares

Amount

Retail (Min)

1

135

₹14,985

Retail (Max)

13

1755

₹1,94,805

S-HNI (Min)

14

1890

₹2,09,790

S-HNI (Max)

66

8910

₹9,89,010

B-HNI (Min)

67

9045

₹10,03,995

Allotment schedule

Basis of Allotment

Yue, Jult 01, 2025

Initiation of Refunds

Wed, Jul 02, 2025

Credit of Shares to Demat

Wed, Jul 02, 2025

Tentative Listing Date

Thu, Jul 03, 2025

Cut-off time for UPI mandate confirmation

5 PM on June 30, 2025

IPO Reservation

Investor Category

Shares Offered

QIB Shares Offered

Not more than 50% of the Net Offer

Retail Shares Offered

Not less than 35% of the Net Offer

NII (HNI) Shares Offered

Not more than 15% of the Net Offer

To check allotment, click here

Download NOVO App!

Invest in Zero-commission Direct Mutual funds, IPO, Sovereign Gold bonds, Government bills, and Corporate bonds.